FDA to Recognize GMP Inspections From Eight EU Countries

International Pharmaceutical Regulatory Monitor
A A
The FDA will begin to recognize manufacturing facility inspections conducted by drug regulatory authorities in Austria, Croatia, France, Italy, Malta, Spain, Sweden and the U.K as capable of meeting the agency’s requirements, as part of 1998 agreement between the U.S. and the European Union renegotiated earlier this year.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor